Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1–2 trial

Bibliographic Details
Title: Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1–2 trial
Authors: Gladwin, Mark T *, Gordeuk, Victor R, Desai, Payal C, Minniti, Caterina, Novelli, Enrico M, Morris, Claudia R, Ataga, Kenneth I, De Castro, Laura, Curtis, Susanna A, El Rassi, Fuad, Ford, Hubert James, Harrington, Thomas, Klings, Elizabeth S, Lanzkron, Sophie, Liles, Darla, Little, Jane, Nero, Alecia, Smith, Wally, Taylor, James G, VI, Baptiste, Ayanna, Hagar, Ward, Kanter, Julie, Kinzie, Amy, Martin, Temeia, Rafique, Amina, Telen, Marilyn J, Lalama, Christina M, Kato, Gregory J, Abebe, Kaleab Z
Source: In The Lancet Haematology May 2024 11(5):e345-e357
Database: ScienceDirect
More Details
ISSN:23523026
DOI:10.1016/S2352-3026(24)00045-0
Published in:The Lancet Haematology
Language:English